Design Therapeutics, Inc.
DSGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807120
No open-market purchases or sales by Design Therapeutics, Inc. insiders were filed in the last 90 days; 136 institutions reported holding it in 13F filings for Q2 2026, worth $626.4M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Design Therapeutics, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 52 | 60 | +8 |
| Shares | 28.3M | 36.2M | +7.89M (+27.9%) |
| Value | $414.8M | $773.1M | +$358.3M (+86.4%) |
New holders (13)
Institutions that held Design Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sr One Capital Management, LP | 5,626,476 | $120.5M | 68.08% |
| Ghost Tree Capital, LLC | 135,000 | $2.89M | 1.11% |
| Tekla Capital Management LLC | 65,351 | $1.40M | 0.05% |
| Qube Research & Technologies Ltd | 23,052 | $494.0K | 0.00% |
| DekaBank Deutsche Girozentrale | 17,000 | $336.0K | 0.00% |
| ProShare Advisors LLC | 13,596 | $291.0K | 0.00% |
| Manufacturers Life Insurance Company, The | 13,126 | $280.0K | 0.00% |
| MetLife Investment Management | 10,864 | $232.6K | 0.00% |
| Wells Fargo & Company | 9,943 | $213.0K | 0.00% |
| Invesco Ltd. | 9,622 | $206.0K | 0.00% |
| Metropolitan Life Insurance Co | 8,048 | $172.3K | 0.00% |
| SG Americas Securities, LLC | 5,639 | $121.0K | 0.00% |
| Daiwa Securities Group Inc. | 162 | $3.00K | 0.00% |
Sold out (5)
Institutions that held Design Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Credit Suisse AG | 235,938 | $3.47M |
| Octagon Capital Advisors LP | 14,926 | $219.0K |
| Millennium Management LLC | 14,169 | $208.0K |
| Piper Sandler & Co. | 2,500 | $37.0K |
| STRS Ohio | 2,000 | $29.0K |